| GO | Name |
| GO:0000902 | cell morphogenesis |
| GO:0001501 | skeletal system development |
| GO:0001540 | amyloid-beta binding |
| GO:0001654 | eye development |
| GO:0001666 | response to hypoxia |
| GO:0001822 | kidney development |
| GO:0001837 | epithelial to mesenchymal transition |
| GO:0001843 | neural tube closure |
| GO:0001942 | hair follicle development |
| GO:0002576 | platelet degranulation |
| GO:0003007 | heart morphogenesis |
| GO:0003148 | outflow tract septum morphogenesis |
| GO:0003149 | membranous septum morphogenesis |
| GO:0003179 | heart valve morphogenesis |
| GO:0003181 | atrioventricular valve morphogenesis |
| GO:0003184 | pulmonary valve morphogenesis |
| GO:0003203 | endocardial cushion morphogenesis |
| GO:0003215 | cardiac right ventricle morphogenesis |
| GO:0003222 | ventricular trabecula myocardium morphogenesis |
| GO:0003274 | endocardial cushion fusion |
| GO:0003289 | atrial septum primum morphogenesis |
| GO:0003407 | neural retina development |
| GO:0005102 | signaling receptor binding |
| GO:0005114 | type II transforming growth factor beta receptor binding |
| GO:0005125 | cytokine activity |
| GO:0005160 | transforming growth factor beta receptor binding |
| GO:0005576 | extracellular region |
| GO:0005615 | extracellular space |
| GO:0006468 | protein phosphorylation |
| GO:0007179 | transforming growth factor beta receptor signaling pathway |
| GO:0007435 | salivary gland morphogenesis |
| GO:0007507 | heart development |
| GO:0008083 | growth factor activity |
| GO:0008219 | cell death |
| GO:0008284 | positive regulation of cell population proliferation |
| GO:0008285 | negative regulation of cell population proliferation |
| GO:0008347 | glial cell migration |
| GO:0008584 | male gonad development |
| GO:0009611 | response to wounding |
| GO:0009792 | embryo development ending in birth or egg hatching |
| GO:0010002 | cardioblast differentiation |
| GO:0010629 | negative regulation of gene expression |
| GO:0010634 | positive regulation of epithelial cell migration |
| GO:0010693 | negative regulation of alkaline phosphatase activity |
| GO:0010718 | positive regulation of epithelial to mesenchymal transition |
| GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0010936 | negative regulation of macrophage cytokine production |
| GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0016477 | cell migration |
| GO:0016525 | negative regulation of angiogenesis |
| GO:0030097 | hemopoiesis |
| GO:0030199 | collagen fibril organization |
| GO:0030307 | positive regulation of cell growth |
| GO:0030308 | negative regulation of cell growth |
| GO:0030326 | embryonic limb morphogenesis |
| GO:0030424 | axon |
| GO:0030509 | BMP signaling pathway |
| GO:0030593 | neutrophil chemotaxis |
| GO:0031069 | hair follicle morphogenesis |
| GO:0031093 | platelet alpha granule lumen |
| GO:0032147 | activation of protein kinase activity |
| GO:0032570 | response to progesterone |
| GO:0032874 | positive regulation of stress-activated MAPK cascade |
| GO:0032909 | regulation of transforming growth factor beta2 production |
| GO:0033630 | positive regulation of cell adhesion mediated by integrin |
| GO:0034714 | type III transforming growth factor beta receptor binding |
| GO:0035910 | ascending aorta morphogenesis |
| GO:0042060 | wound healing |
| GO:0042127 | regulation of cell population proliferation |
| GO:0042416 | dopamine biosynthetic process |
| GO:0042476 | odontogenesis |
| GO:0042493 | response to drug |
| GO:0042704 | uterine wall breakdown |
| GO:0042803 | protein homodimerization activity |
| GO:0043025 | neuronal cell body |
| GO:0043525 | positive regulation of neuron apoptotic process |
| GO:0045216 | cell-cell junction organization |
| GO:0045726 | positive regulation of integrin biosynthetic process |
| GO:0045747 | positive regulation of Notch signaling pathway |
| GO:0045778 | positive regulation of ossification |
| GO:0045787 | positive regulation of cell cycle |
| GO:0045823 | positive regulation of heart contraction |
| GO:0046580 | negative regulation of Ras protein signal transduction |
| GO:0048103 | somatic stem cell division |
| GO:0048566 | embryonic digestive tract development |
| GO:0048666 | neuron development |
| GO:0048699 | generation of neurons |
| GO:0048839 | inner ear development |
| GO:0050680 | negative regulation of epithelial cell proliferation |
| GO:0050714 | positive regulation of protein secretion |
| GO:0050778 | positive regulation of immune response |
| GO:0051781 | positive regulation of cell division |
| GO:0051794 | regulation of timing of catagen |
| GO:0051795 | positive regulation of timing of catagen |
| GO:0051891 | positive regulation of cardioblast differentiation |
| GO:0060038 | cardiac muscle cell proliferation |
| GO:0060065 | uterus development |
| GO:0060317 | cardiac epithelial to mesenchymal transition |
| GO:0060389 | pathway-restricted SMAD protein phosphorylation |
| GO:0060395 | SMAD protein signal transduction |
| GO:0060412 | ventricular septum morphogenesis |
| GO:0060413 | atrial septum morphogenesis |
| GO:0061626 | pharyngeal arch artery morphogenesis |
| GO:0062009 | secondary palate development |
| GO:0062023 | collagen-containing extracellular matrix |
| GO:0097191 | extrinsic apoptotic signaling pathway |
| GO:1902256 | regulation of apoptotic process involved in outflow tract morphogenesis |
| GO:1902895 | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:1903701 | substantia propria of cornea development |
| GO:1904888 | cranial skeletal system development |
| GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |